TY  - JOUR
PY  - 2020//
TI  - STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs
JO  - Age and ageing
A1  - Seppala, Lotta J.
A1  - Petrovic, Mirko
A1  - Ryg, Jesper
A1  - Bahat, Gulistan
A1  - Topinková, Eva
A1  - Szczerbinska, Katarzyna
A1  - van der Cammen, Tischa J. M.
A1  - Hartikainen, Sirpa
A1  - Ilhan, Birkan
A1  - Landi, Francesco
A1  - Morrissey, Yvonne
A1  - Mair, Alpana
A1  - Gutiérrez-Valencia, Marta
A1  - Emmelot-Vonk, Mariëlle H.
A1  - Mora, María Ángeles Caballero
A1  - Denkinger, Michael
A1  - Crome, Peter
A1  - Jackson, Stephen H. D.
A1  - Correa-Pérez, Andrea
A1  - Knol, Wilma
A1  - Soulis, George
A1  - Gudmundsson, Adalsteinn
A1  - Ziere, Gijsbertus
A1  - Wehling, Martin
A1  - O'Mahony, Denis
A1  - Cherubini, Antonio
A1  - van der Velde, Nathalie
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - BACKGROUND: Healthcare professionals are often reluctant to deprescribe fall-risk-increasing drugs (FRIDs). Lack of knowledge and skills form a significant barrier and furthermore, there is no consensus on which medications are considered as FRIDs despite several systematic reviews. To support clinicians in the management of FRIDs and to facilitate the deprescribing process, STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk) and a deprescribing tool were developed by a European expert group.     METHODS: STOPPFall was created by two facilitators based on evidence from recent meta-analyses and national fall prevention guidelines in Europe. Twenty-four panellists chose their level of agreement on a Likert scale with the items in the STOPPFall in three Delphi panel rounds. A threshold of 70% was selected for consensus a priori. The panellists were asked whether some agents are more fall-risk-increasing than others within the same pharmacological class. In an additional questionnaire, panellists were asked in which cases deprescribing of FRIDs should be considered and how it should be performed.     RESULTS: The panellists agreed on 14 medication classes to be included in the STOPPFall. They were mostly psychotropic medications. The panellists indicated 18 differences between pharmacological subclasses with regard to fall-risk-increasing properties. Practical deprescribing guidance was developed for STOPPFall medication classes.     CONCLUSION: STOPPFall was created using an expert Delphi consensus process and combined with a practical deprescribing tool designed to optimise medication review. The effectiveness of these tools in falls prevention should be further evaluated in intervention studies.<p />  <p>Language: en</p>
LA  - en
SN  - 0002-0729
UR  - http://dx.doi.org/10.1093/ageing/afaa249
ID  - ref1
ER  -